Anti-FXYD1/PLM antibody [EPR16081] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal FXYD1/PLM antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human samples.
View Alternative Names
PLM, FXYD1, Phospholemman, FXYD domain-containing ion transport regulator 1, Sodium/potassium-transporting ATPase subunit FXYD1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FXYD1/PLM antibody [EPR16081] - BSA and Azide free (AB251062)
This data was developed using ab191397, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human cardiac muscle tissue labeling FXYD1/PLM with ab191397 at 1/700 dilution followed by pre-diluted HRP Polymer for Rabbit IgG secondary antibody and counter-stained with Hematoxylin.
Inset : Negative control : using PBS instead of primary antibody.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-FXYD1/PLM antibody [EPR16081] - BSA and Azide free (AB251062)
This data was developed using ab191397, the same antibody clone in a different buffer formulation.
Western blot analysis of immunoprecipitation pellet from Human fetal livert lysate immunoprecipitated using ab191397 at 1/90 dilution.
Secondary : Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution.
All lanes:
Immunoprecipitation - Anti-FXYD1/PLM antibody [EPR16081] (<a href='/en-us/products/primary-antibodies/fxyd1-plm-antibody-epr16081-ab191397'>ab191397</a>)
Predicted band size: 10 kDa
false
- WB
Supplier Data
Western blot - Anti-FXYD1/PLM antibody [EPR16081] - BSA and Azide free (AB251062)
This data was developed using ab191397, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-FXYD1/PLM antibody [EPR16081] (<a href='/en-us/products/primary-antibodies/fxyd1-plm-antibody-epr16081-ab191397'>ab191397</a>) at 1/10000 dilution
Lane 1:
Human skeletal muscle lysate at 20 µg
Lane 2:
Human fetal heart tissue lysate at 20 µg
Lane 3:
Human fetal liver tissue lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 10 kDa
false
Related conjugates and formulations (1)
-
Anti-FXYD1/PLM antibody [EPR16081]
Reactivity data
Product details
ab251062 is the carrier-free version of ab191397.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Phospholemman participates in the regulation of cardiac contractility and is involved in muscle relaxation processes. As a component of the Na+/K+-ATPase pump complex it affects the pump's affinity for sodium ions which is important for its normal function. The effector actions of FXYD1 are modulated by phosphorylation allowing it to serve as an important regulator of cardiac output under varying physiological conditions.
Pathways
Phospholemman features in the ion homeostasis and excitability pathway where its action on the Na+/K+-ATPase pump links it to regulation of cardiac action potential. This regulation involves interaction with other membrane proteins like ankyrin which further connects FXYD1 to integrative cardiovascular mechanisms. Additionally FXYD1 impacts membrane hyperpolarization positioning it in the pathway that controls cell excitability and signal transduction in muscle tissues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com